Coulter Partners Top hires for VC & PE portfolio companies Q3-2024

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function, Focus area, Location

CEO, Small molecule biopharma, Australia

CEO, Medical devices, Israel

CEO, Nucleic acid therapies, UK

CEO, Neurostimulation devices, Belgium

Chief Medical Officer, Small molecule/ biologics platform, US

Chief Discovery Officer, Oncology platform technologies, Austria

President EMEA , Drug delivery systems, Germany

VP, Head of Translational Development, Gene writing tools, Spain

VP, People, Cardiac devices, France

Site Head, Plasma derived therapeutics, US

Country General Manager, Veterinary services, Nordics

Commercial Director, Patient monitoring solutions, UK

Marketing & Communications Director, AI for drug discovery, France

Board Director, Oncology focused biotech, UK

Life Sciences Partner, Investor, Europe

Newly opened projects include:

Function, Focus area, Location

CEO, Regenerative medicine, UK

CEO, Biomanufacturing, Sweden

CEO, Contract Research Organization, France

Chief Business Officer, Small molecule therapeutics, Switzerland

Chief Financial Officer, Antibody-drug conjugates, Germany

Chief Operating Officer, Outpatient services, Switzerland

Chief Development Officer, Cell reprogramming, Sweden

Chief Medical Officer, tRNA platform technologies, US

VP, Head of Business Development, Contract Development & Manufacturing Organization, UK

Head of Global Sales, Digital diagnostic devices, Central & E. Europe

Head of Global Distribution, Specialty pharma, France

Country General Manager, Remote patient monitoring, UK

Global Marketing Director, Surgical technologies, US

Board Director, Specialty ingredients, Nordics

Chair, Cardiac devices, Israel